دورية أكاديمية

A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults

التفاصيل البيبلوغرافية
العنوان: A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
المؤلفون: Shaw, Christine A., August, Allison, Bart, Stephan, Booth, Peta-Gay Jackson, Knightly, Conor, Brasel, Trevor, Weaver, Scott C., Zhou, HongHong, Panther, Lori
المصدر: In Vaccine 13 June 2023 41(26):3898-3906
قاعدة البيانات: ScienceDirect
الوصف
تدمد:0264410X
DOI:10.1016/j.vaccine.2023.04.064